Lefamulin最初由Nabriva开发,2018年3月仑胜医药获得在大中华区,包括中国大陆、香港、澳门、台湾开...查看全文
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ UPLOAD [Cover] - SEC-generated letter Filed: 2016-11-02 AccNo: 0000000000-16-099441 Size: 139 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2016-11-29 AccNo: 0001104659-16-159611 Size: 858 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2016-11-29 AccNo: 0001104659-16-159592 Size: 570 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-11-29 AccNo: 0001047469-16-016982 Size: 1 MB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2016-11-22 AccNo: 0001104659-16-158490 Size: 25 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2016-11-16 AccNo: 0001104659-16-157468 Size: 675 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2016-11-14 AccNo: 0001104659-16-156602 Size: 26 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ EFFECT - Notice of Effectiveness Filed: 2016-11-09 AccNo: 9999999995-16-006195 Size: 1 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ F-3/A [Amend] - Registration statement by foreign private issuers Filed: 2016-11-04 AccNo: 0001104659-16-154928 Size: 197 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2016-10-21 AccNo: 0001104659-16-151375 Size: 557 KB 网页链接